Recent Posts

Archived Posts

Blogroll

Pages

 

September 2010
M T W T F S S
« Jun    
 12345
6789101112
13141516171819
20212223242526
27282930  

Meta

Data From Studies of Pfizer Neurontin Drug May Have Been Skewed

November 13, 2009

Researchers say trials of Pfizer Inc.’s Neurontin epilepsy treatment for uses that were not yet approved may have been skewed to emphasize favorable results.

 

Comparisons of internal company documents with published data from 12 clinical trials found inconsistencies between data that made it into the medical journals and findings from the original trials, according to a report in tomorrow’s New England Journal of Medicine. Discrepancies included reports of positive results from trials that were initially found to be negative, and primary study goals reported as secondary study goals.

 

Pfizer paid $430 million in criminal fines and civil penalties in 2004 for urging doctors to prescribe Neurontin for off-label uses. The drugmaker said the new review isn’t credible and the company didn’t attempt to mislead the medical community.

 

Read Article: Bloomberg

 

Posted By: Arizona Phoenix Attorneys for Accidents on the Premises of Others

Post tags:

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment